Organization
National Center for Global Health and Medicine
1 clinical trial
6 abstracts
Abstract
The subgroup analysis by age and geriatric assessment in a phase III study comparison of trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel in older patients with advanced stage HER2-positive breast cancer (JCOG1607 HERB TEA study).Org: National Center for Global Health and Medicine, Shimane University Hospital, Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan,
Abstract
A randomized study comparing electronic patient-reported outcome (ePRO) monitoring with routine follow-up during trastuzumab deruxtecan treatment in patients with metastatic breast cancer (PRO-DUCE study).Org: Department of Breast Surgery, Kansai Medical University Hospital, Osaka, Japan, Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan, Department of Oncology, Sagara Hospital, Kagoshima, Japan, Department of Medical Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan, Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan,
Abstract
The utility of HPV16 E6 as a potential biomarker for HPV-related cancers in HIV-infected men who have sex with men.Org: National Center for Global Health and Medicine, German Cancer Research Center,
Clinical trial
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus: a Multicenter, Open-label, Randomized, Controlled Trial (DIGNITY Trial)Status: Recruiting, Estimated PCD: 2026-08-31
Abstract
Development of an artificial intelligence algorithm for adjuvant chemotherapy based on a nationwide registry of patients with gastric cancer by the Japanese Gastric Cancer Association (JGCA).Org: National Center for Global Health and Medicine, Tokyo, Japan, Healthcare & Life Sciences Services, IBM Japan, Ltd., Japan Medical Association Research Institute,
Abstract
Early changes of PSMA PET signal after initiation of androgen receptor signaling inhibitors in mCRPC: An international multicenter retrospective study.Org: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, UCLA Department of Medicine, Division of Nuclear Medicine,
Abstract
Open-label phase II study of everolimus plus endocrine therapy in postmenopausal women with ER+, HER2- metastatic breast cancer (Chloe trial).Org: National Center for Global Health and Medicine, Teine Keijinkai Hospital, Kansai Medical University Hospital, National Hospital Organization Hokkaido Cancer Center, St. Marianna University School of Medicine Hospital,